ghk-cu 50 mg 50mg GHK-Cu - Simon's Compounding

Interstitial Cystitis A pilot study assessed the safety and efficacy of BPC 157 for interstitial cystitis in 12 women who had not responded to conventional therapies

Someone current on age-appropriate cancer screening (colonoscopy, mammography, PSA testing, skin checks) has more confidence that occult malignancy is not present

A compound of unknown purity administered to a human body introduces risks entirely separate from the compounds own pharmacological profile

Many cancers can recur decades after successful treatment

In the meantime, other well-studied protocols already exist to target these same hallmarks of aging, ranging from pharmacological approaches like rapamycin and SGLT-2 inhibitors to lifestyle strategies such as exercise and caloric restriction

Accessed February 12, 2026